H and B human blood-group antigen expression in cochlear hair cells is modulated by thyroxine.
The presence of human blood-group antigens in developing and adult hypothyroid rat cochleas was analyzed using antibodies directed against antigens H and B. During postnatal development, hypothyroid rat cochleas exhibited a highly selective expression of both B and H antigens, mainly at the hair cell level. Labeling for antigen B was found throughout the hair cells, whereas the antibody directed against antigen H selectively labeled the apical part of these cells. These immunostaining patterns were similar to those found in normal (euthyroid) rat cochleas, but antigenic expression periods were clearly prolonged. Thus, whereas in normal rat cochleas, the B and H antigenic expression disappears from postnatal day (PD) 9 on, in cochleas of hypothyroid rats the reactivity was intense until PD15; it decreased from this developmental stage, and was negative or only faintly positive at PD30. Therefore, in congenital hypothyroidism, hair cell immunoreactivity is present at developmental stages that are negative in normal rat cochleas. These results suggest that human blood-group antigen expression on the developing cochlear hair cells of rats is modulated by thyroxine and that thyroxine is necessary for the temporal expression pattern and secretion of normal glycoproteins.
Gil-Loyzaga
P
P
Dept. Ciencias Morfologicas, Universidad Complutense, Madrid, Spain.
Remezal
M
M
Mollicone
R
R
Ibáñez
A
A
Oriol
R
R
D000017:ABO Blood-Group System / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D000367:Age Factors; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002454:Cell Differentiation; D003051:Cochlea / Q000254:growth & development; D015834:Cochlear Diseases / Q000209:etiology / Q000378:metabolism*; D003409:Congenital Hypothyroidism; D005260:Female; D005455:Fluorescent Antibody Technique; D005786:Gene Expression Regulation / Q000187:drug effects; D006198:Hair Cells, Auditory / Q000378:metabolism*; D007037:Hypothyroidism / Q000150:complications / Q000378:metabolism*; D008713:Methimazole / Q000633:toxicity; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013974:Thyroxine / Q000502:physiology*
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D008713:Methimazole; D013974:Thyroxine